Sire Bioscience Inc. announce the Company has commenced discussions, as well as entered into a non-binding Cannabidiol ("CBD") Commercialization and Consulting Letter of Intent ("LOI"), dated September 24, 2019, with Fusion Nutrition Inc. ("FUSION"). The 20 year old Canadian-based, leading supplement company has national distribution and currently hosts up to 9 brands, including PURPLE-K, the king of creatine. Fusion Nutrition has some of the fastest-growing supplements in Canada and numerous category leaders sold in Canada's top five sports nutrition retailers. To add more depth to their lineup, Fusion is also currently ramping up the release of its protein powder called PROZILLA. The sports nutrition market is vast ­ covering a wide range of categories such as protein powders, protein bars, branched-chain amino acids (BCAAs), pre-workout blends, nitric oxide boosters, and creatine supplements. Largely driven by the Millennial demographic, the market shows no signs of slowing down. According to Allied Market Research, the global sports nutrition market is expected to reach $44 billion by 2021. The non-binding LOI contemplates the branded and private label creation and supply of Sire's House of Brands portfolio of CBD-infused CPG products. Terms of the LOI include but are not limited to: Scientific study and analysis of the CBD/sports nutrition industry to ensure best-in-class deliverable methods. Regulatory analysis to ensure compliance with regulatory bodies in Canada, supporting fastest "go-to-market" strategy. Exclusivity of arrangement between SIRE and FUSION. Exchange of Branding, Licensing and Intellectual Property.